SCHEMBL27804367

SCHEMBL27804367

Cc1oc2cccc(C)c2c1C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
ALDH1A1 P00352 2/20 0.45
APAF1 O14727 1/20 0.45
MAPT P10636 1/20 0.45
HTT P42858 1/20 0.45
RAB9A P51151 1/20 0.45
SLC26A4 O43511 1/20 0.45
TTR P02766 1/20 0.43
DHODH Q02127 1/20 0.43
TDP1 Q9NUW8 2/20 0.42
CYP2C19 P33261 5/20 0.42
EYA3 Q99504 2/20 0.41
EDNRA P25101 1/20 0.41
EGFR P00533 1/20 0.41
MCL1 Q07820 2/20 0.41
KDM4E B2RXH2 1/20 0.40
HPGD P15428 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MEN1 O00255 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6204087 0.84 CA12 (0.50) KMT2AL3MBTL1ALDH1A1APAF1MAPT
SCHEMBL3244639 0.84 POLB (0.50) KMT2AALDH1A1TTRCYP2C19EYA3
SCHEMBL1398779 0.76 CYP2C19 (0.63) KMT2AL3MBTL1ALDH1A1APAF1MAPT
SCHEMBL3612485 0.74 EDNRA (0.66) KMT2AL3MBTL1ALDH1A1MAPTRAB9A
SCHEMBL11732540 0.74 KDM4E (0.45) KMT2AALDH1A1MAPTTTRCYP2C19
SCHEMBL31604813 0.74 CYP2C19 (0.43) KMT2ASLC26A4CYP2C19EYA3MEN1
SCHEMBL355272 0.73 TDP1 (0.61) KMT2AL3MBTL1ALDH1A1TDP1MCL1
SCHEMBL12610891 0.72 KMT2A (0.52) KMT2AALDH1A1MAPTHTTMCL1
SCHEMBL9760981 0.71 CYP2C9 (0.66) KMT2AALDH1A1MAPTHTTRAB9A
SCHEMBL28849644 0.71 EDNRA (0.50) KMT2AALDH1A1MAPTRAB9ATTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116761796-A Aryl derivatives for the treatment of TRPM3 mediated disorders 勒芬天主教大学 2023-09-15 CN disclosed
CN-105209444-B It can be used as the benzo-fused heterocycle derivative of GPR120 activator 詹森药业有限公司 2017-12-29 CN disclosed
CN-102083827-A Thiazolidine compounds as orexin receptor antagonists ACTELION PHARMACEUTICALS LTD 2011-06-01 CN disclosed
CN-101730696-A 3-aza-bicyclo [3.3.0] octane compounds ACTELION PHARMACEUTICALS LTD 2010-06-09 CN disclosed